Drug Shortage Report for QUELICIN

Last updated on 2020-05-14 History
Report ID 111759
Drug Identification Number 00038172
Brand name QUELICIN
Common or Proper name QUELICIN
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) SUCCINYLCHOLINE CHLORIDE
Strength(s) 20MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 25 x 10mL vial
ATC code M03AB
ATC description MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-05-08
Actual start date
Estimated end date
Actual end date 2020-05-13
Shortage status Resolved
Updated date 2020-05-14
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-04-09 English Compare
v2 2020-04-09 French Compare
v3 2020-05-09 English Compare
v4 2020-05-13 English Compare
v5 2020-05-13 French Compare
v6 2020-05-14 English Compare